2023
DOI: 10.3390/pharmaceutics15010278
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character

Abstract: Particle size reduction is a commonly used process to improve the solubility and the dissolution of drug formulations. The solubility of a drug in the gastrointestinal tract is a crucial parameter, because it can greatly influence the bioavailability. This work provides a comprehensive investigation of the effect of the particle size, pH, biorelevant media and polymers (PVA and PVPK-25) on the solubility and dissolution of drug formulations using three model compounds with different acid-base characteristics (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 30 publications
0
2
0
Order By: Relevance
“…Wahyudiono et al reported that the injection of a greater concentration of phospholipids, comprising POPC, into a medium brings about an enhancement in liposome size and PDI [ 53 ]. Previous studies by Csicsák et al and Lee mentioned that the reduction in the size of drug particles can increase their surface area, resulting in an improvement in their dissolution and bioavailability, along with a narrow size distribution for drug particles [ 54 , 55 ]. In other words, decreasing the concentration of POPC utilized to produce liposomal CRE-SD may lead to reduced liposome size and PDI, as well as enhanced bioavailability.…”
Section: Discussionmentioning
confidence: 99%
“…Wahyudiono et al reported that the injection of a greater concentration of phospholipids, comprising POPC, into a medium brings about an enhancement in liposome size and PDI [ 53 ]. Previous studies by Csicsák et al and Lee mentioned that the reduction in the size of drug particles can increase their surface area, resulting in an improvement in their dissolution and bioavailability, along with a narrow size distribution for drug particles [ 54 , 55 ]. In other words, decreasing the concentration of POPC utilized to produce liposomal CRE-SD may lead to reduced liposome size and PDI, as well as enhanced bioavailability.…”
Section: Discussionmentioning
confidence: 99%
“…Droplet size and microstructure of CEONIn general, reducing the particle size leads to an increase in the surface area of particles(Csicsák et al, 2023), especially at the nanoscale. Reducing the average size of essential oil droplets in the nanoemulsion system increases the availability of bioactive compounds and as a result, the antioxidant and antimicrobial properties of the nanoemulsion compared with pure essential oil(Sharifi & Sharifi, 2023).…”
mentioning
confidence: 99%